Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1157/13123977DOI Listing

Publication Analysis

Top Keywords

[influenza vaccine
4
vaccine publishing
4
publishing improve
4
improve coverages]
4
[influenza
1
publishing
1
improve
1
coverages]
1

Similar Publications

Assessment of influenza vaccine effectiveness among the elderly in Taiwan using population-based registry data for the 2023-2024 season.

Vaccine

September 2025

Institute of Statistical Science, Academia Sinica. No.128, Academia Road, Section 2, Nankang, Taipei 11529, Taiwan; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Room 501, No.17, Xu-Zhou Road, Taipei 100, Taiwan; Department of Mathematics, National Taiwan University.

Introduction: Influenza infection can cause serious complications in the elderly, including hospitalizations and death. In Taiwan, government-funded influenza vaccination is offered to the elderly ≥65 years old. We aim to evaluate vaccine effectiveness (VE) among this group during 2023-2024 influenza season using national databases.

View Article and Find Full Text PDF

Influenza vaccination coverage assessments by race and ethnicity can identify populations less protected from influenza morbidity and mortality and help focus vaccination efforts. Across eight Vaccine Safety Datalink health systems, we identified influenza vaccines administered from August 1 through March 31 each season from 2017 to 18 through 2022-23 using electronic health records linked to immunization registries. We calculated crude vaccination coverage for each season among people in five age groups (6 months-8 years, 9-17, 18-49, 50-64, and ≥ 65 years) by self-reported race and ethnicity.

View Article and Find Full Text PDF

In vaccine trials with long-term participant follow-up, it is of great importance to identify surrogate markers that accurately infer long-term immune responses. These markers offer practical advantages such as providing early, indirect evidence of vaccine efficacy, and can accelerate vaccine development while identifying potential biomarkers. High-throughput technologies such as RNA-sequencing have emerged as promising tools for understanding complex biological systems and informing new treatment strategies.

View Article and Find Full Text PDF

For centuries, injections have been the primary method for vaccination; however, these traditional approaches present challenges due to pain, fear, and difficulties in administration. Scientists from Stanford University have developed vaccine creams, representing a revolutionary approach to the field of vaccination. Genetically modified Staphylococcus epidermidis forms the basis of these cream products, which support skin-based, painless vaccination without invasive procedures, while playing an essential role in the immune response.

View Article and Find Full Text PDF

Background: Vaccination is a cornerstone of healthcare systems, and increasing vaccination coverage is crucial for achieving public health objectives globally. However, vaccine acceptance rates vary considerably across different regions worldwide. In China, understanding the determinants of vaccine acceptance is crucial for enhancing coverage and achieving public health goals.

View Article and Find Full Text PDF